Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis

Medical Hypotheses

Volumn 80, Issue 2, 2013, Pages 142-145

  Stommel, Elijah W ^a   Field, Nicholas C ^a   Caller, Tracie A ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLAMINOPROPIONIC ACID; BREVETOXIN;

AEROSOL; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN TISSUE; CYANOBACTERIUM; FOOD CONTAMINATION; GENETIC PREDISPOSITION; HUMAN; LEGIONNAIRE DISEASE; LUNG DISEASE; NEUROTOXICITY; NONHUMAN; RISK FACTOR;

AEROSOLS; AMINO ACIDS, DIAMINO; AMYOTROPHIC LATERAL SCLEROSIS; BACTERIAL TOXINS; CYANOBACTERIA; HUMANS; MODELS, BIOLOGICAL;

BACTERIA (MICROORGANISMS); CYANOBACTERIA; CYCADOPSIDA; PTEROPODIDAE;

EID: 84872286739     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.11.012     Document Type: Article

References (61)

1. Cronin S., Hardiman O., Traynor B.J. Ethnic variation in the incidence of ALS: a systematic review. Neurology 2007, 68(13):1002-1007.
2. Corcia P., Jafari-Schluep H.F., Lardillier D., Mazyad H., Giraud P., Clavelou P., et al. A clustering of conjugal amyotrophic lateral sclerosis in southeastern France. Arch Neurol 2003, 60(4):553-557.
3. Rachele M.G., Mascia V., Tacconi P., Dessi N., Marrosu F., Giagheddu M. Conjugal amyotrophic lateral sclerosis: a report on a couple from Sardinia, Italy. Ital J Neurol Sci 1998, 19(2):97-100.
4. Maloo J.C., Radhakrishnan K., Poddar S.K., Thacker A.K. Conjugal motor neurone disease. J Assoc Physicians India 1989, 37(12):789-790.
5. Melmed C., Krieger C. A cluster of amyotrophic lateral sclerosis. Arch Neurol 1982, 39(9):595-596.
6. Sanders M. Clustering of amyotrophic lateral sclerosis. Jama 1980, 244(5):435.
7. Mulder D.W., Kurland L.T. Motor neuron disease: epidemiologic studies. Adv Exp Med Biol 1987, 209:325-332.
8. Kurland L.T., Mulder D.W. Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution and special reference to the Mariana Islands, including clinical and pathologic observations. Neurology 1954, 4(6):438-448.
9. Zimmerman, HM. Monthly report to the medical officer in command. United States Navy Medical Research Unit No. 2. 1945.
10. Steele J.C. Parkinsonism-dementia complex of Guam. Mov Disord 2005, 20(Suppl 12):S99-S107.
11. Plato C.C., Garruto R.M., Galasko D., Craig U.K., Plato M., Gamst A., et al. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60years. Am J Epidemiol 2003, 157(2):149-157.
12. Whiting M.G. Toxicity of cycads: a literature review. Econ Bot 1963, 17(4):270-302.
13. Spencer P.S., Hugon J., Ludolph A., Nunn P.B., Ross S.M., Roy D.N., et al. Discovery and partial characterization of primate motor-system toxins. Ciba Found Symp 1987, 126:221-238.
14. Bradley W.G., Mash D.C. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotroph Lateral Scler 2009, 10(Suppl 2):7-20.
15. Banack S.A., Cox P.A. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology 2003, 61(3):387-389.
16. Brenner E.D., Stevenson D.W., McCombie R.W., Katari M.S., Rudd S.A., Mayer K.F., et al. Expressed sequence tag analysis in Cycas, the most primitive living seed plant. Genome Biol 2003, 4(12):R78.
17. Cox P.A., Sacks O.W. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology 2002, 58(6):956-959.
18. Banack S.A., Murch S.J., Cox P.A. Neurotoxic flying foxes as dietary items for the Chamorro people Marianas Islands. J Ethnopharmacol 2006, 106(1):97-104.
19. Murch S.J., Cox P.A., Banack S.A. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc Natl Acad Sci USA 2004, 101(33):12228-12231.
20. Murch S.J., Cox P.A., Banack S.A., Steele J.C., Sacks O.W. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol Scand 2004, 110(4):267-269.
21. Pablo J., Banack S.A., Cox P.A., Johnson T.E., Papapetropoulos S., Bradley W.G., et al. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurol Scand 2009, 120(4):216-225.
22. Weiss J.H., Koh J.Y., Choi D.W. Neurotoxicity of beta-N-methylamino-l-alanine (BMAA) and beta-N-oxalylamino-l-alanine (BOAA) on cultured cortical neurons. Brain Res 1989, 497(1):64-71.
23. Rao S.D., Banack S.A., Cox P.A., Weiss J.H. BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp Neurol 2006, 201(1):244-252.
24. Lobner D., Piana P.M., Salous A.K., Peoples R.W. Beta-N-methylamino-l-alanine enhances neurotoxicity through multiple mechanisms. Neurobiol Dis 2007, 25(2):360-366.
25. Liu X., Rush T., Zapata J., Lobner D. Beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-). Exp Neurol 2009, 217(2):429-433.
26. Rodgers K.J., Shiozawa N. Misincorporation of amino acid analogues into proteins by biosynthesis. Int J Biochem Cell Biol 2008, 40:1452-1466.
27. Lee J.W., Beebe K., Nangle L.A., Jang J., Longo-Guess C.M., Cook S.A., et al. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 2006, 443(7107):50-55.
28. Karamyan V.T., Speth R.C. Animal models of BMAA neurotoxicity: a critical review. Life Sci 2008, 82(5-6):233-246.
29. Bell E.A. The discovery of BMAA, and examples of biomagnification and protein incorporation involving other non-protein amino acids. Amyotroph Lateral Scler 2009, 10(Suppl 2):21-25.
30. Brand L.E. Human exposure to cyanobacteria and BMAA. Amyotroph Lateral Scler 2009, 10(Suppl 2):85-95.
31. Brand L.E., Pablo J., Compton A., Hammerschlag N., Mash D.C. Cyanobacterial blooms and the occurrence of the neurotoxin, beta-N-methylamino-l-alanine (BMAA), in South Florida aquatic food webs. Harmful Algae 2010, 10.1016/j.hal.2010.05.002.
32. Jonasson S., Eriksson J., Berntzon L., Spacil Z., Ilag L.L., Ronnevi L.O., et al. Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure. Proc Natl Acad Sci USA 2010, 107(20):9252-9257.
33. Esterhuizen-Londt M., Downing T.G. Solid phase extraction of β-N-methylamino-l-alanine (BMAA) from South African water supplies. Water SA 2011, 37(4):523-527.
34. Qin B., Zhu G., Gao G., Zhang Y., Li W., Paerl H.W., et al. A drinking water crisis in Lake Taihu, China: linkage to climatic variability and lake management. Environ Manage 2010, 45(1):105-112.
35. Fleming L.E., Kirkpatrick B., Backer L.C., Bean J.A., Wanner A., Reich A., et al. Aerosolized red-tide toxins (brevetoxins) and asthma. Chest 2007, 131(1):187-194.
36. Fleming L.E., Bean J.A., Kirkpatrick B., Cheng Y.S., Pierce R., Naar J., et al. Exposure and effect assessment of aerosolized red tide toxins (brevetoxins) and asthma. Environ Health Perspect 2009, 117(7):1095-1100.
37. Morris J.G. Pfiesteria "the cell from hell", and other toxic algal nightmares. Clin Infect Dis 1999, 28(6):1191-1196.
38. Friedman M.A., Levin B.E. Neurobehavioral effects of harmful algal bloom (HAB) toxins: a critical review. J Int Neuropsychol Soc 2005, 11(3):331-338.
39. Parker B.C., Ford M.A., Gruft H., Falkinham J.O. Epidemiology of infection by nontuberculous mycobacteria. IV. Preferential aerosolization of Mycobacterium intracellulare from natural waters. Am Rev Respir Dis 1983, 128(4):652-656.
40. Glazer C.S., Martyny J.W., Lee B., Sanchez T.L., Sells T.M., Newman L.S., et al. Nontuberculous mycobacteria in aerosol droplets and bulk water samples from therapy pools and hot tubs. J Occup Environ Hyg 2007, 4(11):831-840.
41. Backer L.C., Carmichael W., Kirkpatrick B., Williams C., Irvin M., Zhou Y., et al. Recreational exposure to low concentrations of microcystins during an algal bloom in a small lake. Mar Drugs 2008, 6(2):389-406.
42. Backer L.C. McNeel SV, Barber T, Kirkpatrick B, Williams C, Irvin M et al. Recreational exposure to microcystins during algal blooms in two California lakes. Toxicon 2010, 55(5):909-921.
43. Sharma N.K., Singh S. Differential aerosolization of algal and cyanobacterial particles in the atmosphere. Indian J Microbiol 2010, 50(4):468-473.
44. Schlichting H.E. Ejection of microalgae into the air via bursting bubbles. J Allergy Clin Immunol 1974, 53(3):185-188.
45. Cheng Y.S., Zhou Y., Irvin C.M., Kirkpatrick B., Backer L.C. Characterization of aerosols containing microcystin. Mar Drugs 2007, 5(4):136-150.
46. Blanchard D.C., Syzdek L.D. Water-to-air transfer and enrichment of bacteria in drops from bursting bubbles. Appl Environ Microbiol 1982, 43(5):1001-1005.
47. Horner R.D., Kamins K.G., Feussner J.R., Grambow S.C., Hoff-Lindquist J., Harati Y., et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 2003, 61(6):742-749.
48. Armon C. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 2004, 62(6):1027. Author reply 1027-9.
49. Miranda M.L., Alicia Overstreet Galeano M., Tassone E., Allen K.D., Horner R.D. Spatial analysis of the etiology of amyotrophic lateral sclerosis among 1991 Gulf War veterans. Neurotoxicology 2008, 29(6):964-970.
50. Cox P.A., Richer R., Metcalf J.S., Banack S.A., Codd G.A., Bradley W.G. Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans. Amyotroph Lateral Scler 2009, 10(Suppl 2):109-117.
51. Dondero T.J., Rendtorff R.C., Mallison G.F., Weeks R.M., Levy J.S., Wong E.W., et al. An outbreak of Legionnaires disease associated with a contaminated air-conditioning cooling tower. N Engl J Med 1980, 302(7):365-370.
52. Den Boer J.W., Yzerman E.P., Schellekens J., Lettinga K.D., Boshuizen H.C., Van Steenbergen J.E., et al. A large outbreak of Legionnaires' disease at a flower show, the Netherlands, 1999. Emerg Infect Dis 2002, 8(1):37-43.
53. Nygard K., Werner-Johansen O., Ronsen S., Caugant D.A., Simonsen O., Kanestrom A., et al. An outbreak of legionnaires disease caused by long-distance spread from an industrial air scrubber in Sarpsborg. Norway Clin Infect Dis 2008, 46(1):61-69.
54. Greig J.E., Carnie J.A., Tallis G.F., Ryan N.J., Tan A.G., Gordon I.R., et al. An outbreak of Legionnaires' disease at the Melbourne Aquarium, April 2000: investigation and case-control studies. Med J Aust 2004, 180(11):566-572.
55. Akbas E., Yu V.L. Legionnaires' disease and pneumonia. Beware the temptation to underestimate this "exotic" cause of infection. Postgrad Med 2001, 109(5):135-138.
56. Gaylarde P.M., Crispim C.A., Neilan B.A., Gaylarde C.C. Cyanobacteria from Brazilian building walls are distant relatives of aquatic genera. Omics 2005, 9(1):30-42.
57. Uher B., Aboal M., Kovacik L. Cyanobacteria and algae on monuments and buildings in region of Murcia (Spain) (in Slovak). Bull. Slov. Bot. Spoločn. Bratislava 2004, 10:77-82.
58. Rindi F., Guiry M.D. Composition and spatial variability of terrestrial algal assemblages occurring at the bases of urban walls in Europe. Phycologia 2004, 43:225-235.
59. Hauer T. Phototrophic biofilms on the interior walls of concrete Iterson-type cooling towers. J Appl Phycol 2010, 22(6):733-736.
60. Tison D.L., Pope D.H., Cherry W.B., Fliermans C.B. Growth of Legionella pneumophila in association with blue-green algae (cyanobacteria). Appl Environ Microbiol 1980, 39(2):456-459.
61. Stipa G., Taiuti R., de Scisciolo G., Arnetoli G., Tredici M.R., Biondi N., et al. Sporadic amyotrophic lateral sclerosis as an infectious disease: a possible role of cyanobacteria?. Med Hypotheses 2006, 67(6):1363-1371.